Foot and Mouth Disease (FMD) stands as a highly contagious viral ailment impacting cloven-hoofed creatures like cattle, pigs, sheep, and goats. Rooted in the Picornaviridae family, the FMD virus triggers symptoms like fever and blister-like sores on the tongue, mouth, and hooves, causing lameness and a decline in milk production. The virus swiftly disseminates through direct contact, contaminated equipment, or airborne transmission, carrying severe economic consequences due to trade restrictions on affected nations. Preventive strategies encompass vaccination, stringent biosecurity measures, and swift detection via surveillance. Controlling the spread necessitates culling infected animals. Although FMD doesn't typically afflict humans, its impact on global livestock industries is considerable. Ongoing global initiatives concentrate on surveillance, vaccination initiatives, and preparedness planning to effectively manage and curb the spread of Foot and Mouth Disease.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia